Ganga Pharmaceuticals Ltd vs Ortin Global Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 06, 2026

Key Highlights

The Latest Trading Price of Ganga Pharmaceuticals Ltd is ₹ 12 as of 12 Feb 15:30 . The P/E Ratio of Ganga Pharmaceuticals Ltd changed from 113.9 on March 2022 to 63.6 on March 2025 . This represents a CAGR of -13.56% over 4 yearsThe P/E Ratio of Ortin Global Ltd changed from 27.8 on March 2021 to 0 on March 2025 . This represents a CAGR of -100.00% over 5 years The Market Cap of Ganga Pharmaceuticals Ltd changed from ₹ 4.16 crore on March 2022 to ₹ 4.92 crore on March 2025 . This represents a CAGR of 4.28% over 4 yearsThe Market Cap of Ortin Global Ltd changed from ₹ 26.22 crore on March 2021 to ₹ 8.12 crore on March 2025 . This represents a CAGR of -20.90% over 5 years The revenue of Ganga Pharmaceuticals Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Ortin Global Ltd for the Dec '25 is ₹ 0.01 crore as compare to the Sep '25 revenue of ₹ 0.01 crore. This represent the decline of 0% The ebitda of Ganga Pharmaceuticals Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Ortin Global Ltd for the Dec '25 is ₹ -0.05 crore as compare to the Sep '25 ebitda of ₹ -0.5 crore. This represent the decline of -90% The net profit of Ganga Pharmaceuticals Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0% The net profit of Ortin Global Ltd changed from ₹ -0.1 crore to ₹ -0.05 crore over 7 quarters. This represents a CAGR of -32.70% The Dividend Payout of Ganga Pharmaceuticals Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Ortin Global Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Ganga Pharmaceuticals Ltd

Ganga Pharmaceuticals Limited was incorporated as a Public Limited Company in Aug.'94 and promoted by Brij Mohan Sharma.
The Company is engaged in the business of manufacturing & trading in Pharmaceuticals & allied products (Ayurveda). In Apr.'95, the company took over Ganga pharmaceuticals, a proprietary concern (owned by the same promoter), which was manufacturing and marketing ayurvedic products since the last two decades. The company which manufactures ayurvedic medicines, started commercial production in Apr.'95.
In Jul.'96, it came out with a public issue to part-finance the expansion programme involving setting up of a new manufacturing unit for the manufacture of ayurvedic medicines at Murbad, Maharashtra. The company which commenced exports in Jan.'96, has marketing arrangements with parties located in Saudi Arabia, Dubai, Italy, Romania and Russia to market its products in their respective regions.

About Ortin Global Ltd

Ortin Global Limited was initially incorporated as Ortin Laboratories Limited in October 1986 to offer quality Drugs and Medicines to the suffering mankind.
Name of the Company was changed from Ortin Laboratories Limited to Ortin Global Limited with due approval from the ROC, Ministry of Corporate Affairs on June 14, 2024. Company is a leading and predominant Pharmaceutical Manufacturer of Drugs and Medicines in India.
It is engaged in manufacturing and trading of pharmaceuticals, Drugs and Intermediates, to manufacture, sell or export all types of medicines including ayurvedic, homeopathic, unani, biochemical, nature cure, etc and also to engage in real estate. Apart from this, Company also manufacture a range of pharmaceutical formulations of tablets, capsules, syrups, dry powders, and ointments in India.

FAQs for the comparison of Ganga Pharmaceuticals Ltd and Ortin Global Ltd

Which company has a larger market capitalization, Ganga Pharmaceuticals Ltd or Ortin Global Ltd?

Market cap of Ganga Pharmaceuticals Ltd is 7 Cr while Market cap of Ortin Global Ltd is 11 Cr

What are the key factors driving the stock performance of Ganga Pharmaceuticals Ltd and Ortin Global Ltd?

The stock performance of Ganga Pharmaceuticals Ltd and Ortin Global Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Ganga Pharmaceuticals Ltd and Ortin Global Ltd?

As of May 6, 2026, the Ganga Pharmaceuticals Ltd stock price is INR ₹12.0. On the other hand, Ortin Global Ltd stock price is INR ₹14.17.

How do dividend payouts of Ganga Pharmaceuticals Ltd and Ortin Global Ltd compare?

To compare the dividend payouts of Ganga Pharmaceuticals Ltd and Ortin Global Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.